Fisher And Paykel Healthcare Corpo stock

FPH · ASX · AUD

Compare Fisher And Paykel Healthcare Corpo
$40.42Change from previous close: −0.47%Absolute change: −$0.19

Close · November 20, 2026

Price history

+26.67% over the period

1 year: from $31.91 (November 20, 2025) to $40.42 (November 20, 2026), +26.67%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$40.42
October 30, 2026$38.13
September 30, 2026$37.43
August 31, 2026$36.33
July 31, 2026$34.02
June 30, 2026$32.05
May 29, 2026$31.17
April 30, 2026$29.82
March 31, 2026$30.65
February 27, 2026$34.46
January 30, 2026$33.65
December 31, 2025$32.65
November 28, 2025$33.34
November 20, 2025$31.91

At a glance

  • The company

    Designs, manufactures and sells medical devices for respiratory care, sleep apnea treatment, and surgery in acute and chronic settings

  • Latest results

    Quarter to March 31, 2025 · EPS $0.38 (estimate $0.34)

TickerLandia's take on Fisher And Paykel Healthcare Corpo

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$26.51
52-wk high$40.92

−1.22% from the 52-week high

Analysts · 9 analysts

Average target$39.51−2.25% vs. price

Buy 8 · Hold 0 · Sell 1

TickerLandia Fingerprint: Fisher And Paykel Healthcare Corpo

Compared with similar companies: very strong momentum, very high price, and very high profitability.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Fisher And Paykel Healthcare Corpo is pricier than similar companies

Fisher And Paykel Healthcare Corpo's P/E (trailing 12 months): 57.7, +38% against the median of a group of 10 similar companies (41.9).

Compared with 10 similar companies

Fisher And Paykel Healthcare Corpo's metrics compared with similar companies
MetricFisher And Paykel Healthcare CorpoPosition in the groupBand
P/E (trailing 12 months)57.7Middle
Forward P/E45.6High
Operating margin27.6%High
ROE23.4%High
Debt/equity0.07Low

Grey band: the middle half of the group; tick: the median; dot: Fisher And Paykel Healthcare Corpo. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

1.22B id:5

Latest quarter · Q1 2026

Net income

255.5M id:5

Latest quarter · Q1 2026

Quarterly net margin

20.9%

Latest quarter · Q1 2026

Numbers and valuation

Full valuation
Market cap
$23.78B
P/E
57.7
EPS
$0.70
Volume
561.59K
Daily trading
€12.4M
Dividend yield
1.09%
Last ex-dividend on June 22, 2026

How Fisher And Paykel Healthcare Corpo is changing

All results
  • Revenue grew 3.2% a year on average over the last 5 years

  • Operating margin rose from 21.0% to 27.6%

  • Profits turn into cash: free cash flow equal to 103% of net income

Returns

Fisher And Paykel Healthcare Corpo returns

$1,000 invested in Fisher And Paykel Healthcare Corpo 5 years ago, on November 22, 2021, would be worth $1,341 today: +34.06% in total, +6.05% per year. This is the price return only: dividends are excluded.

PeriodFisher And Paykel Healthcare CorpoS&P/ASX 200$1,000 becomes
1 month+1.30%−2.54%$1,013
6 months+47.73%+1.13%$1,477
Year to date+23.80%−1.40%$1,238
1 year+26.67%+0.47%$1,267
3 years+97.56%+21.74%$1,976
5 years+34.06%+16.86%$1,341
10 years+386.99%+60.57%$4,870

Over the last 6 months it has done better than 85% of the stocks in the Healthcare sector.

Price only, without dividends. Calculate your investment

The chart in detail

Fisher And Paykel Healthcare Corpo: technical analysis

Fisher And Paykel Healthcare Corpo is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is at its all-time closing high.

Trend
Upward
RSI (14 sessions)
66
Between 30 and 70
vs 200-session average
+19.92%

Active signals

  • New 52-week high.

    since November 19, 2026

Support and resistance

Price areas where Fisher And Paykel Healthcare Corpo has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price$40.42
  3. Support$36.07−10.75%2 touches, last on November 2, 2026
  4. Support$34.74−14.06%5 touches, last on September 21, 2026
  5. Support$33.73−16.55%3 touches, last on July 7, 2026

Volatility and risk

Over the last year it has moved roughly in line with the S&P/ASX 200.

Beta (1 year) vs S&P/ASX 200
0.82
Volatility (60 sessions, annualised)
18.6%
Largest fall in the last year
−23.14%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Fisher And Paykel Healthcare Corpo: seasonality

Average monthly price change over 25 years

−1.6%Jan−1.1%Feb+1.0%Mar−0.0%Apr+0.6%May+2.4%Jun+2.1%Jul+2.3%Aug+1.0%Sep+0.9%Oct+3.4%Nov+3.0%Dec

Over the last 25 years, the strongest month for Fisher And Paykel Healthcare Corpo has been November: +3.35% on average, positive in 16 years out of 24. The weakest has been January: −1.55% on average, positive in 10 years out of 25.

Show chart data
MonthAverageMedianPositive years
January−1.55%−1.47%10 of 25
February−1.10%+0.68%13 of 25
March+1.01%+1.45%13 of 25
April−0.04%0.00%12 of 25
May+0.59%0.00%12 of 25
June+2.37%+2.10%14 of 25
July+2.06%+1.37%15 of 25
August+2.31%+2.53%15 of 25
September+0.95%+1.32%14 of 25
October+0.88%+0.56%13 of 25
November+3.35%+2.45%16 of 24
December+2.96%+2.20%16 of 25

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Fisher And Paykel Healthcare Corpo and its competitors

Based in Auckland, New Zealand, Fisher & Paykel Healthcare has existed since 1934. The company designs, manufactures and sells medical devices for respiratory care and surgery, including high-flow nasal therapy, invasive and noninvasive ventilation, humidification systems and breathing circuits. Its range also covers infant respiratory products and homecare equipment for treating obstructive sleep apnea, such as CPAP devices, masks and data management software. Hospitals and patients at home are served in North America, Europe, Asia Pacific and other international markets.

Headquarters
Auckland, New Zealand
Employees
7,357
Fisher And Paykel Healthcare Corpo and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Fisher And Paykel Healthcare CorpoFPH$15.85B27.6%57.7+47.73%
Lenskart SolutionsLENSKART$13.82B10.5%163.9+51.79%
Resmed CdiRMD$33.23B34.0%22.3+21.12%
HOYA7741$47.84B34.4%27.3−13.64%
AnsellANN$4.31B15.0%21.6+79.76%
ColoplastCOLO.B$16.42B25.7%36.3+20.27%

Same industry or related industries, similar size. Compare Fisher And Paykel Healthcare Corpo with its competitors · Full profile